{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:23:45Z","timestamp":1778657025854,"version":"3.51.4"},"reference-count":82,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Without a doubt, a majority of diseases are food-pattern-related. However, one disease stands out as an increasingly more common autoimmune-mediated enteropathy triggered by the ingestion of gluten. Celiac disease (CD) is an old disease, with changing clinical patterns, affecting any age, including infancy and adolescence, and becoming more frequent among the elderly. The gluten-free diet (GFD) has been the sole provider of clinical, serological, and histological improvement for patients with CD for more than seven decades. Nowadays, complete avoidance of dietary gluten is rarely possible because of the wide availability of wheat and other processed foods that contain even more gluten, to the detriment of gluten-free products. Undeniably, there is a definite need for replacing the burdensome GFD. An add-on therapy that could control the dietary transgressions and inadvertent gluten consumption that can possibly lead to overt CD should be considered while on GFD. Nevertheless, future drugs should be able to provide patients some freedom to self-manage CD and increase food independence, while actively reducing exposure and mucosal damage and alleviating GI symptoms. Numerous clinical trials assessing different molecules have already been performed with favorable outcomes, and hopefully they will soon be available for patient use.<\/jats:p>","DOI":"10.3390\/ijms232315108","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T01:44:46Z","timestamp":1669945486000},"page":"15108","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Replacing the Burden of the Gluten Free Diet: Then, Now, and the Future"],"prefix":"10.3390","volume":"23","author":[{"given":"Roxana","family":"Nemteanu","sequence":"first","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Institute of Gastroenterology and Hepatology, \u201cSfantul. Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Ciortescu","sequence":"additional","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Institute of Gastroenterology and Hepatology, \u201cSfantul. Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina Elena","family":"Hincu","sequence":"additional","affiliation":[{"name":"Department of Radiology, \u201cSfantul Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Clim","sequence":"additional","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-9340","authenticated-orcid":false,"given":"Liliana","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Department of Radiology, \u201cSfantul Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9144-5520","authenticated-orcid":false,"given":"Anca","family":"Trifan","sequence":"additional","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Institute of Gastroenterology and Hepatology, \u201cSfantul. Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Plesa","sequence":"additional","affiliation":[{"name":"Medical I Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Institute of Gastroenterology and Hepatology, \u201cSfantul. Spiridon\u201d University Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tifs.2020.10.033","article-title":"Recent advances on dietary polyphenol\u2019s potential roles in Celiac Disease","volume":"107","author":"Dias","year":"2021","journal-title":"Trends Food Sci. Technol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kickbusch, I., Ganten, D., and Moeti, M. (2021). The Global Pandemic of Overweight and Obesity. Handbook of Global Health, Springer.","DOI":"10.1007\/978-3-030-45009-0"},{"key":"ref_3","first-page":"357","article-title":"Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: An individual participant data meta-analysis","volume":"77","author":"Trzepizur","year":"2020","journal-title":"Sleep Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1753-4887.2011.00456.x","article-title":"Global nutrition transition and the pandemic of obesity in developing countries","volume":"70","author":"Popkin","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"k2396","DOI":"10.1136\/bmj.k2396","article-title":"Food based dietary patterns and chronic disease prevention","volume":"361","author":"Schulze","year":"2018","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wildman, R.E., and Bruno, R.S. (2019). Handbook of Nutraceuticals and Functional Foods, CRC Press.","DOI":"10.1201\/9780429195594"},{"key":"ref_7","unstructured":"Martins, N., Morales, P., Barros, L., and Ferreira, I.C. (2017). The Increasing Demand for Functional Foods. Wild Plants, Mushrooms and Nuts: Functional Food Properties and Applications, John Wiley & Sons."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnut.2020.00006","article-title":"Pathogenesis of Celiac Disease and Other Gluten Related Disorders in Wheat and Strategies for Mitigating Them","volume":"7","author":"Sharma","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","article-title":"Coeliac disease","volume":"5","author":"Lindfors","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fped.2019.00357","article-title":"Changing Pattern of Childhood Celiac Disease Epidemiology: Contributing Factors","volume":"7","author":"Popp","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14309\/ajg.0000000000000523","article-title":"Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis","volume":"115","author":"King","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cca.2022.01.022","article-title":"Pathophysiology and immunogenetics of celiac disease","volume":"528","author":"Aboulaghras","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174434","DOI":"10.1016\/j.ejphar.2021.174434","article-title":"Current pharmacological approaches and potential future therapies for Celiac disease","volume":"909","author":"Kulkarni","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: A comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1136\/gutjnl-2021-326257","article-title":"Immunopathogenesis and environmental triggers in coeliac disease","volume":"71","author":"Levescot","year":"2022","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddn246","article-title":"Autoimmune diseases: Insights from genome-wide association studies","volume":"17","author":"Lettre","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ye, J., Gillespie, K.M., and Rodriguez, S. (2018). Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era. Genes, 9.","DOI":"10.20944\/preprints201805.0160.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s10038-020-00888-5","article-title":"Independent and cumulative coeliac dis-ease-susceptibility loci are associated with distinct disease phenotypes","volume":"66","author":"Cerqueira","year":"2021","journal-title":"J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3748\/wjg.v28.i4.449","article-title":"Celiac disease: From genetics to epigenetics","volume":"28","author":"Gnodi","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hearn, N.L., Chiu, C.L., and Lind, J.M. (2020). Comparison of DNA methylation profiles from saliva in Coeliac disease and non-coeliac disease individuals. BMC Med. Genom., 13.","DOI":"10.1186\/s12920-020-0670-9"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Megiorni, F., and Pizzuti, A. (2012). HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: Practical implications of the HLA molecular typing. J. Biomed. Sci., 19.","DOI":"10.1186\/1423-0127-19-88"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ejhg.2015.87","article-title":"Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci","volume":"24","author":"Coleman","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"575844","DOI":"10.3389\/fnut.2020.575844","article-title":"Beyond the HLA Genes in Gluten-Related Disorders","volume":"7","author":"Sallese","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Geisslitz, S., Longin, C.F.H., Scherf, K.A., and Koehler, P. (2019). Comparative Study on Gluten Protein Composition of Ancient (Einkorn, Emmer and Spelt) and Modern Wheat Species (Durum and Common Wheat). Foods, 8.","DOI":"10.3390\/foods8090409"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Balakireva, A.V., and Zamyatnin, A.A. (2016). Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities. Nutrients, 8.","DOI":"10.3390\/nu8100644"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cardoso-Silva, D., Delbue, D., Itzlinger, A., Moerkens, R., Withoff, S., Branchi, F., and Schumann, M. (2019). Intestinal Barrier Function in Glu-ten-Related Disorders. Nutrients, 11.","DOI":"10.3390\/nu11102325"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ailioaie, L.M., Ailioaie, C., Litscher, G., and Chiran, D.A. (2022). Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147719"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Paolella, G., Sposito, S., Romanelli, A.M., and Caputo, I. (2022). Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147513"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"674313","DOI":"10.3389\/fimmu.2021.674313","article-title":"Interplay between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease","volume":"12","author":"Voisine","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s12551-021-00856-z","article-title":"Gliadin proteolytical resistant peptides: The interplay between structure and self-assembly in glu-ten-related disorders","volume":"13","author":"Herrera","year":"2021","journal-title":"Biophys. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lindstad, C.B., Dewan, A.E., Stamnaes, J., Sollid, L.M., and du Pr\u00e9, M.F. (2021). TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259082"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1038\/s41598-020-64143-9","article-title":"Identification of Isopeptides between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides","volume":"10","author":"Lexhaller","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.humimm.2021.07.015","article-title":"Diagnosing coeliac disease: A literature review","volume":"82","author":"Gandini","year":"2021","journal-title":"Hum. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1073\/pnas.1914308117","article-title":"A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease","volume":"117","author":"Ting","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T Cells in Celiac Disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3748\/wjg.v21.i24.7349","article-title":"Effector and suppressor T cells in celiac disease","volume":"21","author":"Mazzarella","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fimmu.2020.01374","article-title":"Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder","volume":"11","author":"Dunne","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00042737-200506000-00012","article-title":"Refractory coeliac disease: Remission with infliximab and immunomodulators","volume":"17","author":"Turner","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates in-traepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Ciccocioppo","year":"2006","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14728214.2015.985204","article-title":"Emerging drugs for celiac disease","volume":"20","author":"Freeman","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","article-title":"Most Patients With Celiac Disease on Gluten-Free Diets Consume Measurable Amounts of Gluten","volume":"158","author":"Silvester","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Moreno, M.L., Rodr\u00edguez-Herrera, A., Sousa, C., and Comino, I. (2017). Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Pa-tients. Nutrients, 6.","DOI":"10.3390\/nu9010046"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ajcn\/nqaa188","article-title":"Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: New proposals for follow-up in celiac disease","volume":"112","author":"Fombuena","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/apt.16075","article-title":"Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet","volume":"52","author":"Silvester","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1097\/MCG.0000000000001023","article-title":"Clinical and Microbiological Effect of a Multispecies Pro-biotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Place-bo-controlled, Multicenter Trial","volume":"53","author":"Francavilla","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_49","first-page":"e22031","article-title":"Efficacy of Probiotics in Management of Celiac Disease","volume":"14","author":"Ali","year":"2022","journal-title":"Cureus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.14309\/ajg.0000000000000749","article-title":"Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"115","author":"Seiler","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Moorman, C.D., Sohn, S.J., and Phee, H. (2021). Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.657768"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"643240","DOI":"10.3389\/fimmu.2021.643240","article-title":"Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance","volume":"12","author":"Castenmiller","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wei, G., Helmerhorst, E., Darwish, G., Blumenkranz, G., and Schuppan, D. (2020). Gluten Degrading Enzymes for Treatment of Celiac Disease. Nutrients, 12.","DOI":"10.3390\/nu12072095"},{"key":"ref_55","unstructured":"Britannica, The Editors of Encyclopaedia (2022, October 16). \"Proteolytic Enzyme\". Encyclopedia Britannica, 18 May. Available online: https:\/\/www.britannica.com\/science\/proteolytic-enzyme."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Moreno Amador, M.L., Ar\u00e9valo-Rodr\u00edguez, M., Dur\u00e1n, E.M., Mart\u00ednez Reyes, J.C., and Sousa Mart\u00edn, C. (2019). A new microbial glu-ten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218346"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.dld.2019.11.010","article-title":"Therapeutic options for coeliac disease: What else beyond gluten-free diet?","volume":"52","author":"Caio","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Dieckman, T., Koning, F., and Bouma, G. (2022). Celiac disease: New therapies on the horizon. Curr. Opin. Pharmacol., 66.","DOI":"10.1016\/j.coph.2022.102268"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"112499","DOI":"10.1016\/j.ejmech.2020.112499","article-title":"Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases","volume":"202","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with glutendegrading enzyme by celiac patients: A pi-lot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1756283X17690991","article-title":"Commercially available glutenases: A potential hazard in coeliac disease","volume":"10","author":"Krishnareddy","year":"2017","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Ran-domised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Segura, V., Ruiz-Carnicer, A., Sousa, C., and Moreno, M. (2021). New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options. Nutrients, 13.","DOI":"10.3390\/nu13072146"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.fgb.2017.02.006","article-title":"Mixed colonies of Aspergillus niger and Aspergillus oryzae cooperatively degrading wheat bran","volume":"102","author":"Gruntjes","year":"2017","journal-title":"Fungal Genet. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ehren, J., Mor\u00f3n, B., Martin, E., Bethune, M.T., Gray, G.M., and Khosla, C. (2009). A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006313"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101782","DOI":"10.1016\/j.clinre.2021.101782","article-title":"Larazotide acetate for treatment of celiac disease: A sys-tematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Hoilat","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease During Gluten Challenge","volume":"107","author":"Kelly","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fmed.2018.00187","article-title":"Vaccine Immunotherapy for Celiac Disease","volume":"5","author":"Lenti","year":"2018","journal-title":"Front. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"Randomised clinical trial: A placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gastrohep.2017.12.002","article-title":"New coeliac disease treatments and their complications","volume":"41","author":"Vaquero","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S-490","DOI":"10.1016\/S0016-5085(18)31861-4","article-title":"Su1161-the oral transglutaminase 2 (TG2) inhibitor Zed1227 blocks TG2 activity in a mouse model of intestinal inflammation","volume":"154","author":"Ventura","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","article-title":"Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis","volume":"9","author":"Vicari","year":"2017","journal-title":"mAbs"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: A phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Scheinin","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.gastro.2020.05.016","article-title":"Association between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis","volume":"159","author":"Seiler","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_78","first-page":"7","article-title":"The association between de novo inflammatory bowel disease and celiac disease","volume":"112","year":"2020","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2019-10-2","article-title":"Vedolizumab in the treatment of inflammatory bowel disease: Evolving paradigms","volume":"9","author":"Crooks","year":"2020","journal-title":"Drugs Context"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3748\/wjg.v24.i17.1868","article-title":"Anti-integrin therapy for inflammatory bowel disease","volume":"24","author":"Park","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/gast.2002.31874","article-title":"Successful infliximab treatment for steroid-refractory celiac disease: A case report","volume":"122","author":"Gillett","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/14712598.2020.1798399","article-title":"Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications","volume":"20","author":"Loganathan","year":"2020","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/15108\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:32:15Z","timestamp":1760146335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/15108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":82,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232315108"],"URL":"https:\/\/doi.org\/10.3390\/ijms232315108","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}